Three proposals would build or renovate 529 guest rooms around Mayo Clinic.
Miromatrix, Superior Organoid, and MNPHARM each landed $100,000 regenerative medicine awards.
A collaboration between Mayo and Exact Sciences is yielding accurate blood DNA tests for treatable cases.
The deal will seek to commercialize the Preparing Heart and Mind educational app for parents of babies with heart defects.
Noaber Foundation led a $1.5 million venture round for the digital health platform.
Magenta Therapeutics looks to expand the amount of stem cells for marrow transplants.
The new printer has been proven capable of printing out skin cells to repair wounds in tests on mice.
Cytox Ltd. will use bio-samples from Mayo to develop an algorithm predicting genetic vulnerability.
Partnering company MRI Interventions says the next step will be filing a 510(k), which will come in the third quarter.
The institute will focus on treatments for “cellular senescence” to slow the aging process.
It will play a key role in the U.S. “All of Us” effort to advance individualized medicine.
IPO documents reveal potential of clinic’s collaboration with Evelo Biosciences.